Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check3 days agoChange DetectedThe changes appear to be minor UI/layout tweaks with no modification to core study information such as eligibility criteria, outcomes, drug details, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check25 days agoChange DetectedAdded multiple future dates to the page and removed several earlier dates, signaling updated scheduling/timing information.SummaryDifference0.6%

- Check32 days agoChange DetectedUpdated notice about funding status and updated to v3.2.0 (replacing v3.1.0).SummaryDifference3%

- Check39 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

- Check53 days agoChange DetectedAdds new release notes for v3.0.2 with recent dates and an estimated update label, and removes older July entries and the old v3.0.1 notes to focus on the current release and streamline the history.SummaryDifference0.7%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.